Nxera Pharma Co., Ltd. SOLTF
10.50 USD 0.00 (+0.00%)
At closeNov 9, 2026, 4:00 PM EST
10.50 Day range 10.50
4.90 52-week range 10.93
- YTD
- +91.61%
- 1 year
- +90.91%
- Market cap
- 959.45M
- EPS (ttm)
- -0.40
- YTD return
- +91.61%
- 1-year return
- +90.91%
- Volume
- 100
- Avg volume
- 98
- Open
- 10.50
- Previous close
- 10.50
- Day's range
- 10.50 – 10.50
- 52-week range
- 4.90 – 10.93
No chart data for this range yet.
News
Nxera Pharma Co., Ltd. (SOLTF) Q3 2026 Earnings Call Transcript 
Nxera Pharma Co., Ltd. (SOLTF) Q2 2026 Earnings Call Transcript 
Nxera Joins OpenFold AI Research Consortium Alongside Leading Global Pharmaceutical and AI Companies to Accelerate AI-enabled Drug Discovery 
Nxera's Vamorolone Granted Key Regulatory Designations Supporting Faster Access for Duchenne Muscular Dystrophy Patients in South Korea 
Nxera's President & CEO to Participate in a ‘Fireside Chat' at the Jefferies New York Healthcare Conference 2026 
Nxera Pharma Announces Progress of Out-Licensing of GPCR-targeted Program and Participation in Series A Financing 
Nxera Files Patent Infringement Action in Relation to its miniG Platform Technology 
Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases 
Nxera Pharma Co., Ltd. (OTCMKTS:SOLTF) Short Interest Update 
Nxera Pharma's QUVIVIQ® (daridorexant) 25mg and 50mg Receives Approval in Taiwan for the Treatment of Insomnia
Your note
Sign in to keep a note on SOLTF — it syncs with the Stock Master app.